会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • BROAD-SPECTRUM SEROLOGICAL DIAGNOSTICS AND USES THEREOF
    • 广谱光谱诊断及其用途
    • WO2016191344A1
    • 2016-12-01
    • PCT/US2016/033722
    • 2016-05-23
    • UNIVERSITY OF HOUSTON SYSTEM
    • VARADARAJAN, NavinADOLACION, Jay, R T.WILLSON, Richard, C.
    • C12Q1/68G01N33/543G01N33/68C12N15/10C40B40/10
    • C12N15/1062C12N15/10C12N15/1037C12Q1/68C40B40/10G01N33/543G01N33/68
    • In some embodiments, the present disclosure pertains to method of screening a biological sample for a plurality of diseases. In some embodiments, such a method comprises obtaining a biological sample from a subject in need thereof. In some embodiments, the biological sample comprises a plurality of biomarkers. In some embodiments, each of the plurality of biomarkers is specific for at least one disease. In some embodiments, the method comprises contacting the biological sample with a display library of peptides. In some embodiments, each peptide in the library may have a unique amino acid sequence. In some embodiments, each of the peptides is physically linked to a nucleic acid sequence that identifies of encodes the peptide. In some embodiments, at least one of the peptides is capable of binding to at least one of the biomarkers in the biological sample. In some embodiments, the method comprises separating the bound peptide particles from the unbound peptide particle. In some embodiments, the method comprises eluting the bound peptide particles from the bound state. In some embodiments, the method comprises determining the identity of the nucleic acid sequences physically linked to the bound peptide particles. In some embodiments, the method comprises comparing the sequences thus obtained to a database of sequences representing a plurality of biomarkers of diseases.
    • 在一些实施方案中,本公开涉及筛选多种疾病的生物样品的方法。 在一些实施方案中,这种方法包括从有需要的受试者获得生物样品。 在一些实施方案中,生物样品包含多个生物标志物。 在一些实施方案中,多个生物标志物中的每一个对于至少一种疾病是特异性的。 在一些实施方案中,该方法包括使生物样品与肽的展示文库接触。 在一些实施方案中,文库中的每个肽可以具有唯一的氨基酸序列。 在一些实施方案中,每个肽与识别编码肽的核酸序列物理连接。 在一些实施方案中,至少一种肽能够结合生物样品中的至少一种生物标志物。 在一些实施方案中,该方法包括从未结合的肽颗粒分离结合的肽颗粒。 在一些实施方案中,该方法包括从结合状态洗脱结合的肽颗粒。 在一些实施方案中,该方法包括确定与结合的肽颗粒物理连接的核酸序列的身份。 在一些实施方案中,该方法包括将由此获得的序列与表示多种疾病生物标志物的序列的数据库进行比较。
    • 9. 发明申请
    • SYSTEM AND METHODS FOR NUCLEIC ACID AND POLYPEPTIDE SELECTION
    • 用于核酸和多肽选择的系统和方法
    • WO2005072087A3
    • 2005-11-03
    • PCT/US2004041380
    • 2004-12-10
    • PROTEONOVA INCWILLIAMS RICHARD B
    • WILLIAMS RICHARD B
    • C07H21/04C12Q1/68
    • C12Q1/6811C12N15/1062
    • This invention relates generally to systems and methods for identifying and selecting, desired proteins or nucleic acid molecules by linking mRNA, with known or unknown sequences, to its translated protein to form a cognate pair. The cognate pair is selected based upon desired properties of the protein or the nucleic acid. This method also includes the evolution of a desired protein or nucleic acid molecule by amplifying the nucleic acid portion of the selected cognate pair, introducing variation into the nucleic acid, translating the nucleic acid, attaching the nucleic acid to its protein to form a second cognate pair, and re-selecting this cognate pair based upon desired properties. Modified mRNAs operable to crosslink to tRNAs are also provided. Methods of producing a psoralen monoadduct or a crosslink are also provided. Methods of producing mRNA libraries and vaccines are also provided.
    • 本发明一般涉及通过将mRNA与已知或未知序列连接到其翻译的蛋白质以形成同源对来鉴定和选择所需蛋白质或核酸分子的系统和方法。 基于蛋白质或核酸的所需性质选择同源对。 该方法还包括通过扩增所选择的同源对的核酸部分,引入核酸的变异,翻译核酸,将核酸连接到其蛋白质以形成第二个同源物,从而演化期望的蛋白质或核酸分子 并且基于所需的属性重新选择该同源对。 还提供了可操作以交联至tRNA的修饰的mRNA。 还提供了补骨脂素单加成物或交联剂的制备方法。 还提供了产生mRNA文库和疫苗的方法。